Form 4 for BIO BIO-RAD LABORATORIES, INC.
Accepted 2026-09-09 18:42:11 ET · period of report 2026-09-04 · accession 0000940805-26-000004 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DM | 2026-09-09 18:42 | 2026-09-05+ | BIO | SCHWARTZ NORMAN D | COB, CEO, Dir, 10% | M - OptEx | $0.00 | +7,564 | 450.9K | +2% | $0 |
| DM | 2026-09-09 18:42 | 2026-09-05+ | BIO | SCHWARTZ NORMAN D | COB, CEO, Dir, 10% | F - Tax | $386.11 | -4,730 | 449.0K | -1% | -$1.83M |
| D | 2026-09-09 18:42 | 2026-09-04 | BIO | SCHWARTZ NORMAN D | COB, CEO, Dir, 10% | A - Grant | $0.00 | +17.3K | 17.3K | New | $0 |
| DM | 2026-09-09 18:42 | 2026-09-05+ | BIO | SCHWARTZ NORMAN D | COB, CEO, Dir, 10% | M - OptEx | $0.00 | -7,564 | 6,912 | -52% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Bio-Rad A Common Stock | 2026-09-05 | M | A | 4,109 | $0.00 | 450,294 | D | — | — | (F1) Shares of Class A common stock acquired on the vesting of restricted stock units. |
| 2 | Common | Bio-Rad A Common Stock | 2026-09-05 | F | D | 2,876 | $386.11 | 447,418 | D | — | — | |
| 3 | Common | Bio-Rad A Common Stock | 2026-09-06 | M | A | 3,455 | $0.00 | 450,873 | D | — | — | (F1) Shares of Class A common stock acquired on the vesting of restricted stock units. |
| 4 | Common | Bio-Rad A Common Stock | 2026-09-06 | F | D | 1,854 | $386.11 | 449,019 | D | — | — | |
| 5 | Derivative | Restricted Stock Units | 2026-09-04 | A | A | 17,251 | $0.00 | 17,251 | D | $0.00 · — to — | 17,251 Bio-Rad A Common Stock | (F5) Each restricted stock unit represents a contingent right to receive one share of Bio-Rad Class A common stock. (F6) The restricted stock units vest over four years, with 25% vesting on the first anniversary of the grant date and the remaining units vesting in equal quarterly installments thereafter. (F6) The restricted stock units vest over four years, with 25% vesting on the first anniversary of the grant date and the remaining units vesting in equal quarterly installments thereafter. |
| 6 | Derivative | Restricted Stock Units | 2026-09-05 | M | D | 4,109 | $0.00 | 12,330 | D | $0.00 · — to — | 4,109 Bio-Rad A Common Stock | (F5) Each restricted stock unit represents a contingent right to receive one share of Bio-Rad Class A common stock. (F7) The restricted stock units vest over four years at 25% per year on the yearly anniversary date of the grant. (F7) The restricted stock units vest over four years at 25% per year on the yearly anniversary date of the grant. |
| 7 | Derivative | Restricted Stock Units | 2026-09-06 | M | D | 3,455 | $0.00 | 6,912 | D | $0.00 · — to — | 3,455 Bio-Rad A Common Stock | (F5) Each restricted stock unit represents a contingent right to receive one share of Bio-Rad Class A common stock. (F7) The restricted stock units vest over four years at 25% per year on the yearly anniversary date of the grant. (F7) The restricted stock units vest over four years at 25% per year on the yearly anniversary date of the grant. |